Activist investor William Ackman has taken a roughly $2 billion stake in Zoetis and could push the animal-health company to sell itself to a large drug maker like Valeant Pharmaceuticals.
from WSJ.com: US Business http://ift.tt/1uZZ9kv
via IFTTT
from WSJ.com: US Business http://ift.tt/1uZZ9kv
via IFTTT
No comments:
Post a Comment